Log in or Sign up for Free to view tailored content for your specialty!
Dermatology News
Q&A: Dermatologists can provide valuable experiences for young patients at Camp Discovery
Since 1993, the American Academy of Dermatology has held a unique weeklong summer camp experience for kids aged 8 to 16 years with chronic skin conditions.
Risk for pediatric atopic dermatitis rises with weight gain, drops with weight loss
Gaining weight can raise the risk for atopic dermatitis and possibly other immune-mediated skin diseases in children, whereas losing weight can reduce this risk, according to a study.
Log in or Sign up for Free to view tailored content for your specialty!
After working in garden, patient presents with raised lesions on forearm
A healthy, 19-year-old noticed some pruritic, somewhat raised erythematous lesions on her left forearm (Figure 1). The middle lesion had an unusual linear appearance.
Otezla available in US for treatment of plaque psoriasis in children, adolescents
Otezla is now available in the U.S. for the treatment of moderate to severe plaque psoriasis in children and adolescents aged 6 years and older, Amgen announced in a press release.
FDA approves pediatric indication for NexoBrid for treatment of thermal burns
The FDA has approved a pediatric indication for NexoBrid for the treatment of deep partial-thickness and full-thickness thermal burns, Vericel Corporation announced in a press release.
Q&A: Expert discusses causes of vitiligo as Kim Kardashian opens up about son’s diagnosis
With Kim Kardashian speaking out about her son’s experience with vitiligo, Healio Dermatology sat with an expert to discuss the condition in the adult and pediatric populations.
Early life nutrition could impact psoriasis risk
A higher risk for developing psoriasis was found in subjects who were fed formula as infants compared with those who were breastfed for at least the first 4 months of life, according to a Swedish study.
FDA approves Zoryve for atopic dermatitis in adults, children
The FDA has approved Zoryve cream 0.15% for the treatment of mild to moderate atopic dermatitis in adult and pediatric patients aged 6 years and older, Arcutis announced in a press release.
Clascoterone linked to mild, reversible HPA axis suppression in patients with acne
Clascoterone cream 1% caused mild, reversible hypothalamic-pituitary-adrenal axis suppression under maximum-use exposure in patients with acne vulgaris, according to a study.
Dupilumab associated with reduced risk for atopic march progression
Dupilumab treatment was associated with the reduced risk for atopic march progression in pediatric and adolescent patients with atopic dermatitis, according to a study.
-
Headline News
Q&A: ‘We have to be worried’ about decline in measles vaccination
November 19, 20244 min read -
Headline News
Physicians encouraged to ‘embrace’ technology in practice management
November 19, 20245 min read -
Headline News
Artificial neural network has ‘excellent’ performance in predicting COPD exacerbations
November 20, 20242 min read
-
Headline News
Q&A: ‘We have to be worried’ about decline in measles vaccination
November 19, 20244 min read -
Headline News
Physicians encouraged to ‘embrace’ technology in practice management
November 19, 20245 min read -
Headline News
Artificial neural network has ‘excellent’ performance in predicting COPD exacerbations
November 20, 20242 min read